|
Mutation Information
|
Mutation Site
|
M204V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Combined Mutation
|
rt.L80M+rt.M204V;rt.I80M+rt.M204V |
|
Genotype/Subtype
|
C |
|
Relevant Drug
|
entecavir (ETV) |
Literature Information
|
PubMed PMID
|
28322895
|
|
Published Year
|
2017 |
|
Journal
|
Toxicology and applied pharmacology |
|
Title
|
Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. |
|
Author
|
Huang H,Zhou W,Zhu H,Zhou P,Shi X |
|
Evidence
|
Co-treatment of BA and ETV had a more dramatic effect in NA-resistant HBV(rtM204V/rtLl80M) transfected hepG2 cells.
|
|
|
HBV Mutation Detail Information